These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 10358154

  • 1. New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.
    Mortellaro A, Songia S, Gnocchi P, Ferrari M, Fornasiero C, D'Alessio R, Isetta A, Colotta F, Golay J.
    J Immunol; 1999 Jun 15; 162(12):7102-9. PubMed ID: 10358154
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunosuppressive effect of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through the inhibition of T-lymphocyte proliferation and IL-2 production.
    Yun CH, Son CG, Jung U, Han SH.
    Toxicology; 2006 Jan 05; 217(1):31-8. PubMed ID: 16168555
    [Abstract] [Full Text] [Related]

  • 5. Prodigiosin isolated from Hahella chejuensis suppresses lipopolysaccharide-induced NO production by inhibiting p38 MAPK, JNK and NF-kappaB activation in murine peritoneal macrophages.
    Huh JE, Yim JH, Lee HK, Moon EY, Rhee DK, Pyo S.
    Int Immunopharmacol; 2007 Dec 15; 7(13):1825-33. PubMed ID: 17996695
    [Abstract] [Full Text] [Related]

  • 6. IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes.
    Romano MF, Lamberti A, Petrella A, Bisogni R, Tassone PF, Formisano S, Venuta S, Turco MC.
    J Immunol; 1996 Mar 15; 156(6):2119-23. PubMed ID: 8690900
    [Abstract] [Full Text] [Related]

  • 7. Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation.
    Wong VK, Zhou H, Cheung SS, Li T, Liu L.
    J Cell Biochem; 2009 May 15; 107(2):303-15. PubMed ID: 19301261
    [Abstract] [Full Text] [Related]

  • 8. Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
    Han SB, Park SH, Jeon YJ, Kim YK, Kim HM, Yang KH.
    J Pharmacol Exp Ther; 2001 Nov 15; 299(2):415-25. PubMed ID: 11602650
    [Abstract] [Full Text] [Related]

  • 9. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor.
    Paliogianni F, Ahuja SS, Balow JP, Balow JE, Boumpas DT.
    J Immunol; 1993 Oct 15; 151(8):4081-9. PubMed ID: 8409387
    [Abstract] [Full Text] [Related]

  • 10. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines.
    Pimentel-Muiños FX, Muñoz-Fernández MA, Fresno M.
    J Immunol; 1994 Jun 15; 152(12):5714-22. PubMed ID: 8207202
    [Abstract] [Full Text] [Related]

  • 11. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
    Tocci MJ, Matkovich DA, Collier KA, Kwok P, Dumont F, Lin S, Degudicibus S, Siekierka JJ, Chin J, Hutchinson NI.
    J Immunol; 1989 Jul 15; 143(2):718-26. PubMed ID: 2472451
    [Abstract] [Full Text] [Related]

  • 12. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
    Checker R, Sharma D, Sandur SK, Khanam S, Poduval TB.
    Int Immunopharmacol; 2009 Jul 15; 9(7-8):949-58. PubMed ID: 19374955
    [Abstract] [Full Text] [Related]

  • 13. Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins.
    Erickson S, Sangfelt O, Castro J, Heyman M, Einhorn S, Grandér D.
    Cell Growth Differ; 1999 Aug 15; 10(8):575-82. PubMed ID: 10470857
    [Abstract] [Full Text] [Related]

  • 14. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S, Manabe N, Kubota Y, Ohnishi H, Kitanaka A, Tokuda M, Taminato T, Ishida T, Takahara J, Tanaka T.
    Int Immunopharmacol; 2005 Apr 15; 5(4):699-710. PubMed ID: 15710339
    [Abstract] [Full Text] [Related]

  • 15. Requirement for dual signals by anti-CD40 and IL-4 for the induction of nuclear factor-kappa B, IL-6, and IgE in human B lymphocytes.
    Jeppson JD, Patel HR, Sakata N, Domenico J, Terada N, Gelfand EW.
    J Immunol; 1998 Aug 15; 161(4):1738-42. PubMed ID: 9712038
    [Abstract] [Full Text] [Related]

  • 16. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors.
    Márquez N, Sancho R, Macho A, Calzado MA, Fiebich BL, Muñoz E.
    J Pharmacol Exp Ther; 2004 Mar 15; 308(3):993-1001. PubMed ID: 14617683
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
    Powell JD, Lerner CG, Schwartz RH.
    J Immunol; 1999 Mar 01; 162(5):2775-84. PubMed ID: 10072524
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effect of anethole on T-lymphocyte proliferation and interleukin-2 production through down-regulation of the NF-AT and AP-1.
    Yea SS, Jeong HS, Choi CY, Park KR, Oh S, Shin JG, Yun CH.
    Toxicol In Vitro; 2006 Oct 01; 20(7):1098-105. PubMed ID: 16531003
    [Abstract] [Full Text] [Related]

  • 19. Roles of intracellular calcium and NF-kappa B in the Clostridium difficile toxin A-induced up-regulation and secretion of IL-8 from human monocytes.
    Jefferson KK, Smith MF, Bobak DA.
    J Immunol; 1999 Nov 15; 163(10):5183-91. PubMed ID: 10553038
    [Abstract] [Full Text] [Related]

  • 20. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation.
    Jimenez JL, Punzón C, Navarro J, Muñoz-Fernández MA, Fresno M.
    J Pharmacol Exp Ther; 2001 Nov 15; 299(2):753-9. PubMed ID: 11602691
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.